Table 1 Study Characteristics
First author, year (superscript = references) | Sample size | Duration | Chronic disease | Type | Age in years (mean) | Location |
|---|---|---|---|---|---|---|
Gokal et al., 2016 [35] | 50 | 12 weeks | cancer | breast | 52.00 | home-based |
Huang et al., 2015 [36] | 159 | 12 weeks | cancer | breast | 48.27 | home-based |
Cadmus et al., 2009 [37] | 50 | 24 weeks | cancer | breast | 55.80 | home-based |
Courneya et al., 2009 [38] | 122 | 12 weeks | cancer | lymphoma | 53.20 | clinic-based |
Segal et al., 2008 [39] | 81 | 24 weeks | cancer | prostate | 65.75 | clinic-based |
Al-Majid et al., 2015 [40] | 14 | 12 weeks | cancer | breast | 50.30 | clinic-based |
Courneya et al., 2008 [41] | 242 | 17 weeks | cancer | breast | 50.00 | clinic-based |
Dodd et al., 2010 [42] | 119 | 12 weeks | cancer | breast, colorectal, or ovarian | 50.50 | home-based |
Duijts et al., 2012 [43] | 422 | 12 weeks | cancer | breast | 48.20 | home-based |
Giallauria et al., 2015 [44] | 94 | 52 weeks | cancer | breast | 53.50 | clinic-based |
Nikander et al., 2007 [45] | 28 | 12 weeks | cancer | breast | 53.00 | clinic-based |
Pickett et al., 2002 [46] | 52 | 12 weeks | cancer | breast | 52.00 | home-based |
Shang et al., 2012 [47] | 126 | 20 weeks | cancer | breast, colorectal, or prostate | 60.20 | clinic-based |
Courneya et al., 2003 [48] | 102 | 16 weeks | cancer | colorectal | 60.00 | home-based |
Lian et al., 2014 [49] | 330 | 12 weeks | CVD | coronary artery disease | 62.30 | home-based |
Li et al., 2015 [50] | 77 | 12 weeks | CVD | CVD | 80.68 | home-based |
Salvetti et al., 2008 [51] | 39 | 12 weeks | CVD | coronary disease | 53.00 | home-based |
Gary et al., 2011 [52] | 24 | 12 weeks | CVD | heart failure | 60.00 | home-based |
Guimaraes et al., 2014 [53] | 32 | 12 weeks | CVD | hyper-tension | 53.70 | clinic-based |
Houle et al., 2011 [54] | 65 | 52 weeks | CVD | acute coronary syndrome | 59.00 | home-based |
Kitzman et al., 2010 [55] | 53 | 16 weeks | CVD | heart failure | 70.00 | clinic-based |
Lee et al., 2015 [56] | 80 | 12 weeks | diabetes | type 2 | 56.08 | home-based |
Church et al., 2010 [57] | 113 | 36 weeks | diabetes | type 2 | 55.80 | clinic-based |
Dela et al., 2004 [58] | 24 | 12 weeks | diabetes | type 2 | 51.50 | home-based |
Balducci et al., 2014 [59] | 127 | 48 weeks | diabetes | type 2 | 60.00 | clinic-based |
Negri et al., 2010 [60] | 60 | 16 weeks | diabetes | type 2 | 65.70 | clinic-based |
Nicolucci et al., 2012 [61] | 606 | 49 weeks | diabetes | type 2 | 60.00 | clinic-based |
Sigal et al., 2007 [62] | 251 | 22 weeks | diabetes | type 2 | 53.50 | clinic-based |
Nam et al., 2012 [63] | 140 | 24 weeks | diabetes | type 2 | 56.39 | clinic-based |
Tessier et al., 2000 [64] | 39 | 16 weeks | diabetes | type 2 | 69.40 | clinic-based |